PrimeC — Regulatory decision
Q3 2026
The Company will provide additional updates regarding the regulatory process in Canada once an official response from Health Canada is received, currently expected in the third quarter this year.Source filing
NRSN biotech catalysts & pipeline
NEUROSENSE THERAPEUTICS LTD · Data as of 2026-09-08
Upcoming catalysts
PrimeC — NDA/BLA submission
Dec 2026
This is the approach we are taking in Canada, where, following our discussions with Health Canada, including the pre-NDS process, we are preparing a New Drug Submission (NDS) for PrimeC, which we currently expect to submit in December 2026.Source filing